Flow-injection determination of 3-hdroxybutyrate in serum with an immobilized 3-hydroxybutyrate dehydrogenase reactor and chemiluminescence detection

A flow-injection system for the determination of 3-hydroxybutyrate in serum is described. 3-Hydroxybutyrate dehydrogenase is immobilized on poly(vinyl alcohol) beads and incorporated in a flow-injection system. 1-Methoxy-5-methylphenazinium methylsulphate reacts with enzymatically generated NADH to give H₂O₂, which is detected chemiluminometrically with the reaction of luminol and hexacynoferrate(III). Serum is diluted and filtered through an ultrafiltration membrane. The system responds linearly to injected samples (80 μl) in the concentration range 0.5–300 μM; the detection limit is 0.1 μM. The within-day relative standard deviation (n = 90) for 58 μM 3-hydroxybutyrate in serum is 0.8%. The maximum throughout is 20 samples per hour. The immobilized enzyme is stable for at least 1 month.     

邻苯二甲酸二丁酯对雌二醇与血清组分结合的影响

利用紫外分光光度法测定了邻苯二甲酸二丁酯 (DBP)、雌二醇 (E2 )与血清组分 3种物质间两两结合的二元体系和三元体系结合常数。结果表明 ,DBP、血清组分和 E2 三者之间能两两结合 ,其中以 E2 与血清组分的结合能力最强。当三者处于同一体系中 ,随着 DBP浓度的增加 ,E2 与血清组分 - DBP二元体系间的结合常数也逐渐增加 ,其最大值高出正常 E2 与血清组分结合常数 (7.5 4× 10 4mol-1· L )近一个数量级。这表明 ,DBP的存在可能不会与 E2 对血清组分进行竞争结合 ,但由于本身的结合特点 ,会减少血液中游离E2 的含量 ,从而影响细胞内雌激素的平衡     

Measurement uncertainty of selenium determination in the reference material Seronorm Trace Elements Serum by hydride generation atomic fluorescence spectrometry

 An analytical result is not considered to be complete without a statement of the measurement uncertainty associated with it. Evaluation of measurement uncertainty is therefore an essential part of every determination. In the present study the measurement uncertainty of the result of determination of selenium in the reference material Seronorm Trace Elements Serum was studied. The combination of a digestion procedure using sulfuric acid, V₂O₅ in H₂SO₄ and hydrogen peroxide and the continuous flow approach of hydride generation atomic fluorescence spectrometry (HG-AFS) detection was used for selenium determination. The total uncertainty budget was calculated with the help of the GUM Workbench program, in which computations follow the rules of the ’ISO guide to the expression of uncertainty in measurement’. The major sources of uncertainty were found to be due to the recovery of the procedure, measurement of peak heights and the purity of Na₂SeO₃. A selenium mass fraction of 77.1±4.8 ng/g (with a coverage factor of 2.1, 95% probability) was determined, which is comparable with the recommended value of 80 ng/g. Received: 13 September 2002 Accepted: 23 December 2002 Acknowledgements We would like to thank Tinkara Buˇcar, B.Sc. for useful discussions and the IAEA Vienna, for financial support of the project 11553/RO. Presented at CERMM-3, Central European Reference Materials and Measurements Conference: The function of reference materials in the measurement process, May 30–June 1, 2002, Rogaška Slatina, Slovenia Correspondence to V. Stibilj     

石墨炉原子吸收光谱法测定血清中锰

采用硝酸铵为锰的基体改进剂 ,使用自吸背景校正法 ,测定血清中的痕量锰 ,该法的线性范围为0 .1— 4 0μg/ L;检出限为 1.5 3× 10 -11g;回收率达 96.8%— 10 2 .5 %。     

食管贲门癌患者血清微量元素的变化

检测了３０例食管贲门癌患者手术羊后的ＳＣｕ，ＳＺｎ及Ｃｕ／Ｚｎ比值，并以２８例健康查体者作对照研究，发现：（１）食管贲门癌患者术前血清ＳＣｕ及Ｃｕ／Ｚｎ值高于对照，ＳＺｎ低于对照；（２）肿瘤患者术后１０天血清ＳＣｕ及Ｃｕ／Ｚｎ值下降，ＳＺｎ接近正常，通过本文研究提示，血清ＳＣｕ，ＳＺｎ及Ｃｕ／Ｚｎ比值与食管贲门癌患者的病情和疗效有关，可作为监测和判断病情和预后的辅助检查。     

54例白血病患者血清硒含量分析

以催化极谱法测定了５４例白血病患者血清硒含量。结果表明，急淋、急粒患者血清硒含量均低于正常对照组，慢粒及急、慢粒经治疗缓解者血清硒含量与正常对照组间均无显著性差异，提示低硒状态只存在于急性患者，且随病情缓解后血硒水平趋于正常，慢粒与血硒含量没有明显的相关关系。     

血清硒浓度与口腔鳞癌相关性研究

分析了１９９４￣１９９５年在浙江医科大学附属第一医院门诊的口腔鳞癌患者的血清的硒浓度，结果表明口腔鳞癌患者血清硒浓度极显著低于正常人群，而手术后患者血清硒浓度又极显著高于手术前患者。     

西安地区成年健康人群血清中微量元素正常值研究

用随机抽样的方法对西安地区436名健康人血清中Zn、Fe、Cu、Mn、Pb、Cd、Cr、Ni、Mo和Se十种微量元素正常值进行石墨炉原子吸收光谱法测定，并用ST286型计算机进行多因素相关分析和统计处理．结果表明，血清Zn、Cu分布比较集中，其它元素变异度比较大；多数元素与年龄呈相关关系。其中Zn、Cu、Fe、Mn、Pb、Se与年龄呈正相关 而Mo则与年龄呈负相关；多数元素含量与地城环境中徽量元素的分布有明显的相似性．总之，不同地区不同性别和不同年龄段血清微量元素有显著的差异．     

Analysis of the disaccharides derived from hyaluronic acid and chondroitin sulfate by capillary electrophoresis with sample stacking

CE conditions for monitoring the unsaturated disaccharides of hyaluronic acid (di-HA) and chondroitin sulfate (di-CS) using an alkaline tetraborate buffer, electrokinetic sample injection, and UV absorption detection at 232 nm are reported. Separations were performed in an uncoated fused-silica capillary having reversed polarity and reversed electroosmosis generated with the addition of CTAB to the buffer. The influence of various separation parameters, including the concentration of CTAB, buffer pH, concentration of tetraborate, and applied voltage, on the resolution of the two disaccharides was investigated. Baseline separation was obtained with 25 mM tetraborate at pH 10.0 and having 0.05 mM CTAB. Chloride and phosphate in the sample are beneficial for the stacking of the disaccharides, with di-HA forming a much sharper peak than di-CS. Using samples prepared in 25 mM Tris-HCl (pH 7.5) and electrokinetic injection at the cathode at -10 kV for 40 s, linear relationships between the corrected peak area and the concentration of the disaccharides have been found in the ranges of 1.0-400.0 and 0.1-1.0 microg/mL (0.2-1.0 microg/mL for di-CS), with correlation coefficients being >0.9933 in all cases. The RSDs of detection times and corrected peak areas were between 1.13-1.24 and 1.57-2.13%, respectively. Applied to human serum samples that were prepared by ethanol precipitation and depolymerization of the two polysaccharides with chondroitinase ABC reveals comigration of endogenous compounds with di-HA and a sample-dependent detection time. The di-HA content in the serum sample can be estimated via subtraction of the blank peak that is obtained without enzymatic hydrolysis.     

Rapid and sensitive liquid chromatography-tandem mass spectrometry for the quantitation of epirubicin and identification of metabolites in biological samples

A highly sensitive and selective liquid chromatography-mass spectrometry (LC-MS) method has been developed for the determination of epirubicin in serum and cell specimens using daunorubicin as an internal standard. Using atmospheric pressure chemical ionisation (APCI), the epirubicin metabolites were readily distinguishable by their fragmentation pattern in the mass spectrometer. Selected reaction monitoring (SRM) mode was employed for quantitation of epirubicin and the metabolites. Following extraction, chromatography was performed on a C18 column with a mobile phase consisting of water-acetonitrile-formic acid, pH 3.2, with a flow rate of 200 μl/min. The limit of detection (LOD) and the limit of quantitation (LOQ) of this method in serum were determined to be 1.0 and 2.5 ng/ml, respectively. Linearity of the method was verified over the concentration range of 2.5-2000 ng/ml, with a high correlation coefficient (R² ≥ 0.998). For the extraction procedure, an aliquot of 500 μl serum, spiked with internal standard, was extracted using a chloroform-2-isopropanol (2:1, v/v) mixture. The method has been applied to the analysis of epirubicin in cancer cell samples and the identification of known and unknown metabolites in clinical trial patient serum samples.